NEW YORK (Reuters Health) – Pooled data from multiple studies indicate that repetitive transcranial magnetic stimulation (rTMS) is useful for depression, auditory verbal hallucinations, and possibly for negative…
NEW YORK (Reuters Health) – In nondiabetics, high glucose levels signal an increased risk for contrast-induced acute kidney injury during coronary angiography, new research suggests. “Although diabetes is…
NEW YORK (Reuters Health) – Treatment with dutasteride reduces incident prostate cancers in men with high prostate specific antigen (PSA) levels, according to a report in The New…
NEW YORK (Reuters Health) – If asymptomatic lower pole renal calculi require intervention, percutaneous nephrolithotomy will provide a higher stone-free rate than shock wave lithotripsy, and with less…
NEW YORK (Reuters Health) – Once-a-week treatment with long-acting exenatide (Byetta) produces sustained glycemic control and weight loss in diabetics, a multicenter trial has shown. “This study confirms…
NEW YORK (Reuters Health) – Sertraline plus naltrexone is more effective than either agent alone in promoting abstinence in depressed alcohol-dependent patients, according to study findings in the…
NEW YORK (Reuters Health) – Percutaneous tibial nerve stimulation is an effective therapy for overactive bladder symptoms, according to a report in the April issue of The Journal…
NEW YORK (Reuters Health) – In diabetics with heart failure, use of metformin is associated with a lower risk of mortality than use of other anti-diabetic agents, even…
NEW YORK (Reuters Health) – Adjuvant chemotherapy, with or without postoperative radiotherapy, improves survival in patients with operable non-small-cell lung cancer, according to a March 24th online report…
NEW YORK (Reuters Health) – The anticonvulsant topiramate (Topamax) helps treat alcohol dependence, but serious side effects might limit its use, researchers say. In their systematic review, Dr.…
